|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
29,950,000 |
Market
Cap: |
98.84(M) |
Last
Volume: |
42,300 |
Avg
Vol: |
41,959 |
52
Week Range: |
$2.13 - $3.97 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Computer Hardware |
Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 5 |
Insider 6 Months : 11 |
Insider 3/6 Months : 16.4 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
10,000 |
88,289 |
129,011 |
243,345 |
Total Buy Value |
$28,500 |
$214,541 |
$339,819 |
$675,842 |
Total People Bought |
1 |
4 |
4 |
4 |
Total Buy Transactions |
1 |
9 |
14 |
25 |
Total Shares Sold |
0 |
0 |
0 |
11,800 |
Total Sell Value |
$0 |
$0 |
$0 |
$42,126 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kumar Amit |
Chief Executive Officer |
|
2025-06-04 |
4 |
B |
$2.85 |
$28,500 |
D/D |
10,000 |
569,925 |
2.74 |
15% |
|
Baskies Arnold M |
Director |
|
2025-01-28 |
4 |
B |
$2.82 |
$14,100 |
D/D |
5,000 |
120,000 |
2.39 |
-1% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-24 |
4 |
B |
$3.00 |
$3,000 |
D/D |
1,000 |
933,334 |
2.31 |
-1% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-23 |
4 |
B |
$2.91 |
$5,820 |
D/D |
2,000 |
932,334 |
2.39 |
-3% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-22 |
4 |
B |
$3.01 |
$6,020 |
D/D |
2,000 |
930,334 |
2.39 |
-3% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-21 |
4 |
B |
$2.59 |
$15,540 |
D/D |
6,000 |
928,334 |
2.39 |
-9% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-17 |
4 |
B |
$2.57 |
$25,700 |
D/D |
10,000 |
922,334 |
2.39 |
8% |
|
Kumar Amit |
Chief Executive Officer |
|
2025-01-15 |
4 |
B |
$2.23 |
$95,890 |
D/D |
43,000 |
559,925 |
2.74 |
10% |
|
Catelani Michael |
President, COO, & CFO |
|
2025-01-15 |
4 |
B |
$2.15 |
$19,971 |
D/D |
9,289 |
44,500 |
2.74 |
10% |
|
Titterton Lewis H Jr |
Director |
|
2024-10-22 |
4 |
OE |
$2.58 |
$41,200 |
D/D |
16,000 |
912,334 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2024-07-31 |
4 |
B |
$3.23 |
$18,023 |
D/D |
5,580 |
896,334 |
2.39 |
-10% |
|
Titterton Lewis H Jr |
Director |
|
2024-07-30 |
4 |
B |
$3.06 |
$66,237 |
D/D |
21,646 |
890,754 |
2.39 |
3% |
|
Baskies Arnold M |
Director |
|
2024-07-26 |
4 |
B |
$3.09 |
$15,450 |
D/D |
5,000 |
115,000 |
2.39 |
6% |
|
Titterton Lewis H Jr |
Director |
|
2024-07-26 |
4 |
B |
$3.03 |
$23,331 |
D/D |
7,700 |
869,108 |
2.39 |
6% |
|
Titterton Lewis H Jr |
Director |
|
2024-07-25 |
4 |
B |
$2.81 |
$2,237 |
D/D |
796 |
861,408 |
2.31 |
15% |
|
Titterton Lewis H Jr |
Director |
|
2024-06-14 |
4 |
B |
$2.68 |
$10,720 |
D/D |
4,000 |
860,612 |
2.39 |
21% |
|
Titterton Lewis H Jr |
Director |
|
2024-06-13 |
4 |
B |
$2.70 |
$1,094 |
D/D |
405 |
856,612 |
2.31 |
16% |
|
Titterton Lewis H Jr |
Director |
|
2024-06-11 |
4 |
B |
$2.66 |
$18,891 |
D/D |
7,102 |
856,207 |
2.39 |
17% |
|
Titterton Lewis H Jr |
Director |
|
2024-06-10 |
4 |
B |
$2.60 |
$858 |
D/D |
330 |
849,105 |
2.31 |
13% |
|
Titterton Lewis H Jr |
Director |
|
2024-06-07 |
4 |
B |
$2.52 |
$27,060 |
D/D |
10,738 |
848,775 |
2.39 |
17% |
|
Kumar Amit |
Chief Executive Officer |
|
2024-06-07 |
4 |
B |
$2.41 |
$60,250 |
D/D |
25,000 |
516,925 |
2.74 |
17% |
|
Catelani Michael |
President, COO, & CFO |
|
2024-06-07 |
4 |
B |
$2.40 |
$15,000 |
D/D |
6,250 |
35,211 |
2.74 |
17% |
|
Catelani Michael |
President, COO, & CFO |
|
2024-04-30 |
4 |
A |
$2.52 |
$2,996 |
D/D |
1,189 |
28,961 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2024-04-09 |
4 |
B |
$3.28 |
$49,230 |
D/D |
15,009 |
838,037 |
2.39 |
-5% |
|
Kumar Amit |
Chief Executive Officer |
|
2024-03-15 |
4 |
B |
$3.22 |
$96,600 |
D/D |
30,000 |
491,925 |
2.74 |
-17% |
|
190 Records found
|
|
Page 1 of 8 |
|
|